Neurocircuitry in alcoholism: a substrate of disruption and repair Edith V. SullivanAdolf Pfefferbaum Review 15 April 2005 Pages: 583 - 594
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study A. R. Lingford-HughesS. J. WilsonD. J. Nutt Original Investigation 28 April 2005 Pages: 595 - 606
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users Jörg DaumannThomas FischermannEuphrosyne Gouzoulis-Mayfrank Original Investigation 15 September 2004 Pages: 607 - 611
Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals K. D. ErscheP. C. FletcherB. J. Sahakian Original Investigation 15 March 2005 Pages: 612 - 623
Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes Ulrich MüllerJ. SucklingE. T. Bullmore Original Investigation 14 April 2005 Pages: 624 - 633
Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation Christine M. TipperTara A. CairoElton T. C. Ngan Original Investigation 28 June 2005 Pages: 634 - 643
A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory Sasha E. B. GibbsMark D'Esposito Original Investigation 07 July 2005 Pages: 1 - 10
The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels Mitul A. MehtaDeepa GumastePaul M. Grasby Original Investigation 26 January 2005 Pages: 654 - 663
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride James M. StoneRodrigo A. BressanLyn S. Pilowsky Original Investigation 18 February 2005 Pages: 664 - 669
Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces Roshan CoolsAndy J. CalderTrevor W. Robbins Original Investigation 17 March 2005 Pages: 670 - 679
Neuronal effects of acute citalopram detected by pharmacoMRI S. McKieC. Del-BenJ. F. W. Deakin Original Investigation 12 May 2005 Pages: 680 - 686
Methodological considerations in rat brain BOLD contrast pharmacological MRI C. A. StewardC. A. MarsdenY. B. Shah Review 19 March 2005 Pages: 687 - 704
Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging Yin-Ching I. ChenJi-Kyung ChoiBruce G. Jenkins Original Investigation 05 November 2004 Pages: 705 - 715
Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder Katherine N. HewittYasmene B. ShahCharles A. Marsden Original Investigation 28 April 2005 Pages: 716 - 723
Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia Céline RisterucciKarine JeanneauJean-Luc Moreau Original Investigation 22 February 2005 Pages: 724 - 734
D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats Abesh Kumar BhattacharjeeLisa ChangStanley I. Rapoport Original Investigation 15 March 2005 Pages: 735 - 742
Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging Nicholas JonesMichael J. O’NeillSteve C. R. Williams Original Investigation 28 April 2005 Pages: 743 - 751
Effect of Thunbergia laurifolia, a Thai natural product used to treat drug addiction, on cerebral activity detected by functional magnetic resonance imaging in the rat Watchareewan ThongsaardCharles A. MarsdenYasmene B. Shah Original Investigation 02 July 2005 Pages: 1 - 9
Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats Y. B. ShahL. HaynesV. Chapman Original Investigation 19 March 2005 Pages: 761 - 773
The phenylephrine blood pressure clamp in pharmacologic magnetic resonance imaging: reduction of systemic confounds and improved detectability of drug-induced BOLD signal changes Raffael KalischMarina DelfinoDorothee P. Auer Original Investigation 28 April 2005 Pages: 774 - 780
Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain Thomas J. R. BeveridgeHilary R. SmithLinda J. Porrino Original Investigation 01 March 2005 Pages: 781 - 788
A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist A. Lingford-HughesS. J. WilsonD. J. Nutt Letter to the Editors 29 June 2005 Pages: 1 - 3
